Oxidative status imbalance in patients with metabolic syndrome: Role of the myeloperoxidase/hydrogen peroxide axis

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Fonseca, Lucas José Sá Da ^a   Nunes Souza, Valéria ^a,b,c   Guedes, Glaucevane Da Silva ^a,b   Schettino Silva, Glauber ^a   Mota Gomes, Marco Antônio ^d   Rabelo, Luíza Antas ^a,b,c  

^a FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^b Instituto Nacional de Ciência e Tecnologia em NanoBiofarmacêutica N BIOFAR Avenida Antônio Carlos S n   (Brazil)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d Centro de Pesquisas Clínicas Do Hospital Do Coração de Alagoas HCOR AL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

METABOLIC SYNDROMES; MYELOPEROXIDASE; OXIDATIVE STATUS;

ARGINASE; CATALASE; HYDROGEN PEROXIDE; MYELOPEROXIDASE; NITRITE; SUPEROXIDE DISMUTASE; PEROXIDASE;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; RADIAL ARTERY; VENOUS BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

CASE-CONTROL STUDIES; FEMALE; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; PEROXIDASE;

EID: 84908344277     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/898501     Document Type: Article

References (55)

1. Aoqui C., Chmielewski S., Scherer E., Eißler R., Sollinger D., Heid I., Braren R., Schmaderer C., Megens R. T. A., Weber C., Heemann U., Tschöp M., Baumann M., Microvascular dysfunction in the course of metabolic syndrome induced by high-fat diet. Cardiovascular Diabetology 2014 13 1, article 31 10.1186/1475-2840-13-31 2-s2.0-84893191273
2. Grundy S. M., Cleeman J. I., Daniels S. R., Donato K. A., Eckel R. H., Franklin B. A., Gordon D. J., Krauss R. M., Savage P. J., Smith S. C. Jr., Spertus J. A., Costa F., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005 112 17 2735 2752 10.1161/CIRCULATIONAHA.105.169404 2-s2.0-27444443876
3. Alberti K. G. M. M., Eckel R. H., Grundy S. M., Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 120 16 1640 1645 10.1161/CIRCULATIONAHA.109.192644 2-s2.0-70350245011
4. Otani H., Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxidants and Redox Signaling 2011 15 7 1911 1926 10.1089/ars.2010.3739 2-s2.0-80051993151
5. Grattagliano I., Palmieri V. O., Portincasa P., Moschetta A., Palasciano G., Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. Journal of Nutritional Biochemistry 2008 19 8 491 504 10.1016/j.jnutbio.2007.06.011 2-s2.0-46749149676
6. Sánchez-Rodríguez M. A., Martínez-Cruz M., Correa-Muñoz E., Mendoza-Núñez V. M., Relationship between metabolic syndrome components and oxidative stress in elderly community-dwelling mexicans. Annals of Nutrition and Metabolism 2010 56 4 302 307 10.1159/000309601 2-s2.0-77953125184
7. Li C. I., Kardia S. L., Liu C. S., Lin W. Y., Lin C. H., Lee Y. D., Sung F. C., Li T. C., Lin C. C., Metabolic syndrome is associated with change in subclinical arterial stiffness-a community-based Taichung Community Health Study. BMC Public Health 2011 11, article 808 10.1186/1471-2458-11-808 2-s2.0-80054054680
8. Armutcu F., Ataymen M., Atmaca H., Gurel A., Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome. Clinical Chemistry and Laboratory Medicine 2008 46 6 785 790 10.1515/CCLM.2008.166 2-s2.0-44949130582
9. Wolin M. S., Reactive oxygen species and the control of vascular function. American Journal of Physiology-Heart and Circulatory Physiology 2009 296 3 H539 H549 10.1152/ajpheart.01167.2008 2-s2.0-64049083005
10. Taniyama Y., Griendling K. K., Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003 42 6 1075 1081 10.1161/01.HYP.0000100443.09293.4F 2-s2.0-0348109425
11. Ceriello A., Motz E., Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 5 816 823 10.1161/01.ATV.0000122852.22604.78 2-s2.0-2442421194
12. Kleinbongard P., Dejam A., Lauer T., Jax T., Kerber S., Gharini P., Balzer J., Zotz R. B., Scharf R. E., Willers R., Schechter A. N., Feelisch M., Kelm M., Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radical Biology and Medicine 2006 40 2 295 302 10.1016/j.freeradbiomed.2005.08.025 2-s2.0-30344474311
13. Demircan N., Gürel A., Armutcu F., Ünalacak M., Aktunç E., Atmaca H., The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome. Medical Science Monitor 2008 14 2 CR97 CR101 2-s2.0-39349091237
14. Galijasevic S., Saed G. M., Diamond M. P., Abu-Soud H. M., Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition. Proceedings of the National Academy of Sciences of the United States of America 2003 100 25 14766 14771 10.1073/pnas.2435008100 2-s2.0-0344736701
15. Davies M. J., Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. Journal of Clinical Biochemistry and Nutrition 2011 48 1 8 19 10.3164/jcbn.11-006FR 2-s2.0-78650750400
16. Abu-Soud H. M., Hazen S. L., Nitric oxide modulates the catalytic activity of myeloperoxidase. The Journal of Biological Chemistry 2000 275 8 5425 5430 10.1074/jbc.275.8.5425 2-s2.0-0034102068
17. Azekoshi Y., Yasu T., Watanabe S., Tagawa T., Abe S., Yamakawa K., Uehara Y., Momomura S., Urata H., Ueda S., Free fatty acid causes leukocyte activation and resultant endothelial dysfunction through enhanced angiotensin II production in mononuclear and polymorphonuclear cells. Hypertension 2010 56 1 136 142 10.1161/HYPERTENSIONAHA.110.153056 2-s2.0-77953806919
18. von Leitner E.-C., Klinke A., Atzler D., Slocum J. L., Lund N., Kielstein J. T., Maas R., Schmidt-Haupt R., Pekarova M., Hellwinkel O., Tsikas D., D'Alecy L. G., Lau D., Willems S., Kubala L., Ehmke H., Meinertz T., Blankenberg S., Schwedhelm E., Gadegbeku C. A., Böger R. H., Baldus S., Sydow K., Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase. Circulation 2011 124 24 2735 2745 10.1161/CIRCULATIONAHA.111.060541 2-s2.0-83455230998
19. Baldus S., Rudolph V., Roiss M., Ito W. D., Rudolph T. K., Eiserich J. P., Sydow K., Lau D., Szöcs K., Klinke A., Kubala L., Berglund L., Schrepfer S., Deuse T., Haddad M., Risius T., Klemm H., Reichenspurner H. C., Meinertz T., Heitzer T., Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 2006 113 15 1871 1878 10.1161/CIRCULATIONAHA.105.590083 2-s2.0-33646170866
20. Nicholls S. J., Hazen S. L., Myeloperoxidase and cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 6 1102 1111 10.1161/01.ATV.0000163262.83456.6d 2-s2.0-20144383475
21. Cacoub P., Cambou J. P., Kownator S., Belliard J. P., Beregi J. P., Branchereau A., Carpentier P., Léger P., Luizy F., Maïza D., Mihci E., Herrmann M. A., Priollet P., Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional study. International Journal of Clinical Practice 2009 63 1 63 70 10.1111/j.1742-1241.2008.01953.x 2-s2.0-57649159610
22. Yubero-Serrano E. M., Delgado-Lista J., Peña-Orihuela P., Perez-Martinez P., Fuentes F., Marin C., Tunez I., Tinahones F. J., Perez-Jimenez F., Roche H. M., Lopez-Miranda J., Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study. Experimental and Molecular Medicine 2013 45 6, article e28 10.1038/emm.2013.53 2-s2.0-84881143950
23. Alberti K. G. M. M., Zimmet P., Shaw J., The metabolic syndrome-a new worldwide definition. The Lancet 2005 366 9491 1059 1062 10.1016/S0140-6736(05)67402-8 2-s2.0-25144459980
24. Takazawa K., Kobayashi H., Shindo N., Tanaka N., Yamashina A., Relationship between radial and central aeterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave. Hypertension Research 2007 30 3 219 228 10.1291/hypres.30.219 2-s2.0-34247228666
25. Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. C., Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 7 412 419 10.1007/BF00280883 2-s2.0-0021813187
26. Bostom A. G., Kronenberg F., Ritz E., Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. Journal of the American Society of Nephrology 2002 13 8 2140 2144 10.1097/01.ASN.0000022011.35035.F3 2-s2.0-0036069880
27. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 10.1016/0003-2697(79)90738-3 2-s2.0-0018384650
28. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 1976 72 1-2 248 254 10.1016/0003-2697(76)90527-3 2-s2.0-0017184389
29. Xu P., Costa-Goncalves A. C., Todiras M., Rabelo L. A., Sampaio W. O., Moura M. M., Santos S. S., Luft F. C., Bader M., Gross V., Alenina N., Santos R. A. S., Endothelial dysfunction and elevated blood pressure in Mas gene-deleted mice. Hypertension 2008 51 2 574 580 10.1161/HYPERTENSIONAHA.107.102764 2-s2.0-38549174602
30. Misko T. P., Schilling R. J., Salvemini D., Moore W. M., Currie M. G., A fluorometric assay for the measurement of nitrite in biological samples. Analytical Biochemistry 1993 214 1 11 16 10.1006/abio.1993.1449 2-s2.0-0027527363
31. Corraliza I. M., Campo M. L., Soler G., Modolell M., Determination of arginase activity in macrophages: a micromethod. Journal of Immunological Methods 1994 174 1-2 231 235 10.1016/0022-1759(94)90027-2 2-s2.0-0027934360
32. Simão A. N. C., Dichi J. B., Barbosa D. S., Cecchini R., Dichi I., Influence of uric acid and γ -glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Nutrition 2008 24 7-8 675 681 10.1016/j.nut.2008.03.021 2-s2.0-44749093098
33. Fujita K., Nishizawa H., Funahashi T., Shimomura I., Shimabukuro M., Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circulation Journal 2006 70 11 1437 1442 10.1253/circj.70.1437 2-s2.0-33750562169
34. Bandeira S. D. M., Guedes G. D. S., Fonseca L. J. S. D., Pires A. S., Gelain D. P., Moreira J. C. F., Rabelo L. A., Vasconcelos S. M. L., Goulart M. O. F., Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity. Oxidative Medicine and Cellular Longevity 2012 2012 13 819310 10.1155/2012/819310 2-s2.0-84870208571
35. Ziobro A., Duchnowicz P., Mulik A., Koter-Michalak M., Broncel M., Oxidative damages in erythrocytes of patients with metabolic syndrome. Molecular and Cellular Biochemistry 2013 378 1-2 267 273 10.1007/s11010-013-1617-7 2-s2.0-84886786963
36. Félétou M., Vanhoutte P. M., Endothelial dysfunction: a multifaceted disorder. American Journal of Physiology: Heart and Circulatory Physiology 2006 291 3 H985 H1002 10.1152/ajpheart.00292.2006 2-s2.0-33748421398
37. Fukai T., Ushio-Fukai M., Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxidants & Redox Signaling 2011 15 6 1583 1606 10.1089/ars.2011.3999 2-s2.0-79961193678
38. Viroonudomphol D., Pongpaew P., Tungtrongchitr R., Phonrat B., Supawan V., Vudhivai N., Schelp F. P., Erythrocyte antioxidant enzymes and blood pressure in relation to overweight and obese Thai in Bangkok. Southeast Asian Journal of Tropical Medicine and Public Health 2000 31 2 325 334 2-s2.0-0034198385
39. Biasucci L. M., D'Onofrio G., Liuzzo G., Zini G., Monaco C., Caligiuri G., Tommasi M., Rebuzzi A. G., Maseri A., Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. Journal of the American College of Cardiology 1996 27 3 611 616 10.1016/0735-1097(95)00524-2 2-s2.0-0029966043
40. Kim J. A., Choi Y. S., Hong J. I., Kim S. H., Jung H. H., Kim S. M., Association of metabolic syndrome with white blood cell subtype and red blood cells. Endocrine Journal 2006 53 1 133 139 10.1507/endocrj.53.133 2-s2.0-33644938769
41. Babio N., Ibarrola-Jurado N., Bulló M., White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study. PLoS ONE 2013 8 3 e58354 10.1371/journal.pone.0058354 2-s2.0-84875096135
42. Liu Y., Wang D., Li D., Sun R., Xia M., Associations of retinol-binding protein 4 with oxidative stress, inflammatory markers, and metabolic syndrome in a middle-aged and elderly Chinese population. Diabetology and Metabolic Syndrome 2014 6 1, article 25 10.1186/1758-5996-6-25 2-s2.0-84896694314
43. Laurent S., Cockcroft J., van Bortel L., Expert consensus document on arterial stiffness: methodological issues and clinical applications. European Heart Journal 2006 27 21 2588 2605 10.1093/eurheartj/ehl254 2-s2.0-33750318148
44. Mitchell G. F., Hwang S.-J., Vasan R. S., Larson M. G., Pencina M. J., Hamburg N. M., Vita J. A., Levy D., Benjamin E. J., Arterial stiffness and cardiovascular events: the framingham heart study. Circulation 2010 121 4 505 511 10.1161/CIRCULATIONAHA.109.886655 2-s2.0-76349084693
45. McEniery C. M., Wallace S., MacKenzie I. S., McDonnell B., Newby D. E., Cockcroft J. R., Wilkinson I. B., Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 2006 48 4 602 608 10.1161/01.HYP.0000239206.64270.5f 2-s2.0-33750575381
46. Nelson M. R., Stepanek J., Cevette M., Covalciuc M., Hurst R. T., Tajik A. J., Noninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform? Mayo Clinic Proceedings 2010 85 5 460 472 10.4065/mcp.2009.0336 2-s2.0-77951721505
47. Kovaite M., Petrulioniene Z., Ryliskyte L., Badariene J., Dzenkeviciute V., Cypiene A., Laucevicius A., Polena S., Gintautas J., Systemic assessment of arterial wall structure and function in metabolic syndrome. Proceedings of the Western Pharmacology Society 2007 50 123 130 2-s2.0-48249083010
48. Lüscher T. F., Creager M. A., Beckman J. A., Cosentino F., Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: part II. Circulation 2003 108 13 1655 1661 10.1161/01.CIR.0000089189.70578.E2 2-s2.0-0141730235
49. Wilkinson I. B., Hall I. R., MacCallum H., Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 1 147 152 10.1161/hq0102.101770 2-s2.0-0036141944
50. Simão A. N. C., Lozovoy M. A. B., Simão T. N. C., Venturini D., Barbosa D. S., Dichi J. B., Matsuo T., Cecchini R., Dichi I., Immunological and biochemical parameters of patients with metabolic syndrome and the participation of oxidative and nitroactive stress. Brazilian Journal of Medical and Biological Research 2011 44 7 707 712 10.1590/S0100-879X2011000700015 2-s2.0-79961063533
51. x level with clustering of metabolic syndrome components in middle-aged and elderly general populations in Japan. Environmental Health and Preventive Medicine 2008 13 1 36 42 10.1007/s12199-007-0001-1 2-s2.0-42049089974
52. Hornig B., Landmesser U., Kohler C., Ahlersmann D., Spiekermann S., Christoph A., Tatge H., Drexler H., Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 2001 103 6 799 805 10.1161/01.CIR.103.6.799 2-s2.0-0035852775
53. Grigore L., Raselli S., Garlaschelli K., Redaelli L., Norata G. D., Pirillo A., Catapano A. L., Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia. European Journal of Clinical Pharmacology 2013 69 3 341 346 10.1007/s00228-012-1345-z 2-s2.0-84877145351
54. Kashyap S. R., Lara A., Zhang R., Young M. P., DeFronzo R. A., Insulin reduces plasma arginase activity in type 2 diabetic patients. Diabetes Care 2008 31 1 134 139 10.2337/dc07-1198 2-s2.0-38149109904
55. Katusic Z. S., Mechanisms of endothelial dysfunction induced by aging: role of arginase I. Circulation Research 2007 101 7 640 641 10.1161/CIRCRESAHA.107.162701 2-s2.0-34848896935